NCT04300296 · Interventional trial
PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus
Overall registry status Completed
Phase 2
Conditions Lichen Planus: Cutaneous Lichen Planus, Mucosal Lichen Planus and Lichen Planopilaris
Delaware Valley sites
- Novartis Investigative Site · East Windsor, NJ · Mercer County
First posted
Registry updated
Added to the directory